Ran GTPase Activating Protein 1 (RANGAP1) (N-Term) Peptid
RANGAP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle RANGAP1 Produkte
- RANGAP1 (Ran GTPase Activating Protein 1 (RANGAP1))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RANGAP1 antibody (Catalog #: ARP56509_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
Ran GTPase Activating Protein 1 (RANGAP1) peptide
RANGAP1 Reaktivität: Human, Maus, Rind (Kuh), Hund, Ratte Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RANGAP1 (Ran GTPase Activating Protein 1 (RANGAP1))
- Hintergrund
-
RanGAP1, is a homodimeric 65-kD polypeptide that specifically induces the GTPase activity of RAN, but not of RAS by over 1,000-fold. RanGAP1 is the immediate antagonist of RCC1, a regulator molecule that keeps RAN in the active, GTP-bound state. The RANGA
Alias Symbols: Fug1, KIAA1835, MGC20266, SD
Protein Interaction Partner: SUMO1,UBE2I,CSNK2A1,IPO8,RAN,RANBP2,RANGAP1,SUMO1,SUMO2,SUMO3,UBE2I,C19orf62,GSP1,MEPCE,PMS1,RAN,RANGAP1,SIZ1,SUMO1,Senp2,UBE2I
Protein Size: 587 - Molekulargewicht
- 63 kDa
- Gen-ID
- 5905
- NCBI Accession
- NM_002883, NP_002874
- UniProt
- P46060
-
Sie sind hier:
